Post-stroke cognitive impairment and dementia
Poststroke cognitive impairment and dementia (PSCID) is a major source of morbidity and
mortality after stroke worldwide. PSCID occurs as a consequence of ischemic stroke …
mortality after stroke worldwide. PSCID occurs as a consequence of ischemic stroke …
Low‐field MRI: clinical promise and challenges
Modern MRI scanners have trended toward higher field strengths to maximize signal and
resolution while minimizing scan time. However, high‐field devices remain expensive to …
resolution while minimizing scan time. However, high‐field devices remain expensive to …
[HTML][HTML] Dementia epidemiology fact sheet 2022
JH Shin - Annals of Rehabilitation Medicine, 2022 - synapse.koreamed.org
This dementia epidemiology fact sheet 2022 is aimed at providing an overview of the
epidemiology of dementia in Korea using representative government-led data. This review …
epidemiology of dementia in Korea using representative government-led data. This review …
[HTML][HTML] Vascular cognitive impairment (VCI)
Vascular cognitive impairment (VCI) is predominately caused by vascular risk factors and
cerebrovascular disease. VCI includes a broad spectrum of cognitive disorders, from mild …
cerebrovascular disease. VCI includes a broad spectrum of cognitive disorders, from mild …
The prevalence of dementia: a systematic review and meta-analysis
Q Cao, CC Tan, W Xu, H Hu, XP Cao… - Journal of …, 2020 - content.iospress.com
Dementia is a severe neurodegenerative disorder and it can be categorized into several
subtypes by different pathogenic causes. We sought to comprehensively analyzed the …
subtypes by different pathogenic causes. We sought to comprehensively analyzed the …
[HTML][HTML] Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
Background China has a large population of older people, but has not yet undertaken a
comprehensive study on the prevalence, risk factors, and management of both dementia …
comprehensive study on the prevalence, risk factors, and management of both dementia …
Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases
Therapies directed toward the central nervous system remain difficult to translate into
improved clinical outcomes. This is largely due to the blood–brain barrier (BBB), arguably …
improved clinical outcomes. This is largely due to the blood–brain barrier (BBB), arguably …
[HTML][HTML] Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive …
C Cicognola, S Janelidze, J Hertze… - Alzheimer's research & …, 2021 - Springer
Introduction Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
Molecular biomarkers for vascular cognitive impairment and dementia
S Hosoki, GK Hansra, T Jayasena, A Poljak… - Nature Reviews …, 2023 - nature.com
As disease-specific interventions for dementia are being developed, the ability to identify the
underlying pathology and dementia subtypes is increasingly important. Vascular cognitive …
underlying pathology and dementia subtypes is increasingly important. Vascular cognitive …
Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta‐analysis
Objective The present study aimed to resolve inconsistency in reported prevalence of
affective symptoms by dementia stage. Methods/Design We conducted a meta‐analysis of …
affective symptoms by dementia stage. Methods/Design We conducted a meta‐analysis of …